Illumina (ILMN)
(Delayed Data from NSDQ)
$109.22 USD
+0.71 (0.65%)
Updated Jun 13, 2024 04:00 PM ET
3-Hold of 5 3
D Value B Growth A Momentum B VGM
Brokerage Reports
Illumina, Inc. [ILMN]
Reports for Purchase
Showing records 261 - 280 ( 361 total )
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Higher Quality 4Q14 Results - Entire System Portfolio Outperforms - FCF Improving - Several Ways to Win in 2015 - Upping PT to $230 - Maintain OP
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of Jan 26
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
President''s Precision Med Initiative Light on Details - Expecting In-line 4Q14 Results Post Preannouncement - Gov''t Orders Ok - Maintain OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Expecting Ok 4Q14 Results - Dx Theme In Focus - Potential NIH Program Helps Calm 2015 Growth Fears - Gov''t Tracker In-line - Maintain OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
NIPT Update - Confusing Study/Letter Creates a Slight Near-Term Distraction
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
NIPT Update - Confusing Study/Letter Creates a Slight Near-Term Distraction - NIPT Strategy - MO Likely Unaffected - Maintain OP
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Banner 3Q14 Results - System Demand Drives Beat Again - Utilization Ok & NIPT Sales Inflect Nicely - Guidance Upped - Reiterating OP
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Banner 3Q14 Results - System Demand Drives Beat Again - Utilization Ok & NIPT Sales Inflect Nicely - Guidance Upped - Reiterating OP
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Expecting Robust 3Q14 Results - Continue to Hear of Quiet Pre-Natal Licensing Deals
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Medical Diagnostics and Life Sciences Tools - Ariosa Publishes New NIPT Approach
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Pre-Natal & Gov''t Update - Deep Discussion with New US NIPT Player - Ariosa Sends Letter to LabCorp Customers - VA Activity Intriguing - Maintain OP
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Strong 2Q14 Beat Driven By X Ten & NextSeq Placements - System Utilization Not As Strong - Good GM and FCF Progress - Raising PT to $165 - Maintain N
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
LIFE SCIENCES AND HEALTH CARE-The Week Ahead in Life Sciences - Upcoming Events for the Week of July 21
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Gov''t Demand Tracker Indicates Positively - Tweaking Street-High Estimates Slightly Lower - 2Q14 Beat Setup Still Looks Solid
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Checks Suggest ILMN Has Won an Exclusive Competitive Contract with Progenity
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Checks Suggest ILMN Has Won an Exclusive Competitive Contract with Progenity
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z